XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Based Compensation - Stock Appreciation Rights (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Weighted Average Grant Date Fair Value    
Grant price (in USD per share) $ 10  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding $ 135,000  
Unrecognized compensation expense $ 11,000 $ 149,000
Stock Appreciation Rights (SARs)    
Number of Shares    
Beginning Balance (in shares) 177,016  
Granted (in shares) 0  
Exercised (in shares) 0  
Forfeited (in shares) 0  
Ending Balance (in shares) 177,016  
Exercisable at the end of period (in shares) 124,801  
Weighted Average Grant Date Fair Value    
Beginning balance (in dollars per share) $ 2.57  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0  
Forfeited (in dollars per share) 0  
Ending balance (in dollars per share) 2.57  
Exercisable at the period end (in dollars per share) $ 2.57  
Stock Appreciation Rights (SARs) | General and Administrative Expense    
Weighted Average Grant Date Fair Value    
Compensation costs $ 33,000 $ 30,000